FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:EPC1-L3MBTL4

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: EPC1-L3MBTL4
FusionPDB ID: 26891
FusionGDB2.0 ID: 26891
HgeneTgene
Gene symbol

EPC1

L3MBTL4

Gene ID

80314

91133

Gene nameenhancer of polycomb homolog 1L3MBTL histone methyl-lysine binding protein 4
SynonymsEpl1HsT1031
Cytomap

10p11.22

18p11.31

Type of geneprotein-codingprotein-coding
Descriptionenhancer of polycomb homolog 1lethal(3)malignant brain tumor-like protein 4H-l(3)mbt-like protein 4L3MBTL4, histone methyl-lysine binding protein
Modification date2020031320200313
UniProtAcc

Q9H2F5

Main function of 5'-partner protein: FUNCTION: Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when directly recruited to sites of DNA damage. {ECO:0000269|PubMed:14966270}.

Q8NA19

Main function of 5'-partner protein: FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins maintain the transcriptionally repressive state of genes, probably via a modification of chromatin, rendering it heritably changed in its expressibility (By similarity). {ECO:0000250}.
Ensembl transtripts involved in fusion geneENST idsENST00000263062, ENST00000319778, 
ENST00000375110, ENST00000480402, 
ENST00000535782, ENST00000578677, 
ENST00000284898, ENST00000317931, 
ENST00000400104, ENST00000400105, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score17 X 14 X 8=190415 X 12 X 6=1080
# samples 2016
** MAII scorelog2(20/1904*10)=-3.25096157353322
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(16/1080*10)=-2.75488750216347
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: EPC1 [Title/Abstract] AND L3MBTL4 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: EPC1 [Title/Abstract] AND L3MBTL4 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)EPC1(32580090)-L3MBTL4(6301956), # samples:2
Anticipated loss of major functional domain due to fusion event.EPC1-L3MBTL4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
EPC1-L3MBTL4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneEPC1

GO:0000122

negative regulation of transcription by RNA polymerase II

10976108

HgeneEPC1

GO:0043967

histone H4 acetylation

14966270

HgeneEPC1

GO:0043968

histone H2A acetylation

14966270

HgeneEPC1

GO:0045814

negative regulation of gene expression, epigenetic

10976108

HgeneEPC1

GO:0045892

negative regulation of transcription, DNA-templated

10976108

HgeneEPC1

GO:0045944

positive regulation of transcription by RNA polymerase II

10976108



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr10:32580090/chr18:6301956)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across EPC1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across L3MBTL4 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000375110EPC1chr1032580090-ENST00000400105L3MBTL4chr186301956-444411302812929882
ENST00000375110EPC1chr1032580090-ENST00000317931L3MBTL4chr186301956-441711302812902873
ENST00000375110EPC1chr1032580090-ENST00000284898L3MBTL4chr186301956-444311302812929882
ENST00000375110EPC1chr1032580090-ENST00000400104L3MBTL4chr186301956-539111302812662793
ENST00000319778EPC1chr1032580090-ENST00000400105L3MBTL4chr186301956-459212783033077924
ENST00000319778EPC1chr1032580090-ENST00000317931L3MBTL4chr186301956-456512783033050915
ENST00000319778EPC1chr1032580090-ENST00000284898L3MBTL4chr186301956-459112783033077924
ENST00000319778EPC1chr1032580090-ENST00000400104L3MBTL4chr186301956-553912783032810835
ENST00000263062EPC1chr1032580090-ENST00000400105L3MBTL4chr186301956-455912452703044924
ENST00000263062EPC1chr1032580090-ENST00000317931L3MBTL4chr186301956-453212452703017915
ENST00000263062EPC1chr1032580090-ENST00000284898L3MBTL4chr186301956-455812452703044924
ENST00000263062EPC1chr1032580090-ENST00000400104L3MBTL4chr186301956-550612452702777835

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000375110ENST00000400105EPC1chr1032580090-L3MBTL4chr186301956-0.0002071060.9997929
ENST00000375110ENST00000317931EPC1chr1032580090-L3MBTL4chr186301956-0.0002068810.9997931
ENST00000375110ENST00000284898EPC1chr1032580090-L3MBTL4chr186301956-0.0002071740.9997929
ENST00000375110ENST00000400104EPC1chr1032580090-L3MBTL4chr186301956-0.0002899060.99971
ENST00000319778ENST00000400105EPC1chr1032580090-L3MBTL4chr186301956-0.0001173130.9998827
ENST00000319778ENST00000317931EPC1chr1032580090-L3MBTL4chr186301956-0.0001153890.9998846
ENST00000319778ENST00000284898EPC1chr1032580090-L3MBTL4chr186301956-0.0001172380.9998827
ENST00000319778ENST00000400104EPC1chr1032580090-L3MBTL4chr186301956-0.0001818260.99981815
ENST00000263062ENST00000400105EPC1chr1032580090-L3MBTL4chr186301956-0.0001166760.9998833
ENST00000263062ENST00000317931EPC1chr1032580090-L3MBTL4chr186301956-0.0001148950.9998851
ENST00000263062ENST00000284898EPC1chr1032580090-L3MBTL4chr186301956-0.0001166920.9998833
ENST00000263062ENST00000400104EPC1chr1032580090-L3MBTL4chr186301956-0.0001821530.9998179

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for EPC1-L3MBTL4

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
EPC1chr1032580090L3MBTL4chr1863019561130278SQFKHQEAMDVKEFKVNKEQAEEEKK
EPC1chr1032580090L3MBTL4chr1863019561245320SQFKHQEAMDVKEFKVNKEQAEEEKK
EPC1chr1032580090L3MBTL4chr1863019561278320SQFKHQEAMDVKEFKVNKEQAEEEKK

Top

Potential FusionNeoAntigen Information of EPC1-L3MBTL4 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
EPC1-L3MBTL4_32580090_6301956.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B44:03QEAMDVKEF0.99890.9756514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B47:01QEAMDVKEF0.99830.5641514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:60AMDVKEFKV0.99580.5792716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:24AMDVKEFKV0.99570.5864716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:30AMDVKEFKV0.99570.5864716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:67AMDVKEFKV0.99570.5864716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:11AMDVKEFKV0.99540.6328716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B18:01QEAMDVKEF0.99380.9434514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:04AMDVKEFKV0.99360.6478716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:21AMDVKEFKV0.99220.7241716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:16AMDVKEFKV0.98870.5189716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:38AMDVKEFKV0.98090.6591716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:35AMDVKEFKV0.96080.6279716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:13AMDVKEFKV0.94670.6905716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B45:01QEAMDVKEF0.8930.9635514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:29AMDVKEFKV0.86110.59716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:20AMDVKEFKV0.85380.5981716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B45:01KEFKVNKEQA0.9750.70631121
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B13:01HQEAMDVKEF0.94610.9653414
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B44:03HQEAMDVKEF0.92520.981414
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B44:05HQEAMDVKEF0.83490.5272414
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B41:01KEFKVNKEQA0.71910.72631121
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B50:01KEFKVNKEQA0.67250.58881121
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B38:01KHQEAMDVKEF0.99840.9778314
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B38:02KHQEAMDVKEF0.99810.9804314
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B44:03KHQEAMDVKEF0.97420.9736314
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-C05:09AMDVKEFKV0.99990.964716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B40:03QEAMDVKEF0.99660.5282514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:07AMDVKEFKV0.99590.6622716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:01AMDVKEFKV0.99570.5864716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B44:09HQEAMDVKEF0.88690.5532414
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B44:10HQEAMDVKEF0.8480.5313414
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B35:24EAMDVKEF0.99660.8839614
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B35:43EAMDVKEF0.99340.8618614
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B18:07EAMDVKEF0.96950.8846614
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-C05:01AMDVKEFKV0.99990.964716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-C04:03AMDVKEFKV0.99990.8902716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-C18:01AMDVKEFKV0.99980.8613716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B44:26QEAMDVKEF0.99890.9756514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B44:07QEAMDVKEF0.99890.9756514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B44:13QEAMDVKEF0.99890.9756514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B18:07QEAMDVKEF0.99540.918514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B18:11QEAMDVKEF0.99460.9288514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B18:04QEAMDVKEF0.99390.9494514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B18:05QEAMDVKEF0.99380.9434514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:14AMDVKEFKV0.99230.6103716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A02:06AMDVKEFKV0.99220.7241716
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B18:06QEAMDVKEF0.99180.9441514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B18:08QEAMDVKEF0.99120.8968514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B40:04QEAMDVKEF0.9890.7776514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B18:03QEAMDVKEF0.97990.9376514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B35:20QEAMDVKEF0.8160.9848514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B15:53QEAMDVKEF0.68470.8794514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B48:02QEAMDVKEF0.61770.98514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B41:03QEAMDVKEF0.5080.7724514
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A68:02EAMDVKEFKV0.99880.5811616
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A69:01EAMDVKEFKV0.99780.6067616
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B15:24HQEAMDVKEF0.99420.8858414
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B15:53HQEAMDVKEF0.99190.8495414
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B15:12HQEAMDVKEF0.97960.898414
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B44:07HQEAMDVKEF0.92520.981414
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B44:26HQEAMDVKEF0.92520.981414
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B44:13HQEAMDVKEF0.92520.981414
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B50:05KEFKVNKEQA0.67250.58881121
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B50:04KEFKVNKEQA0.67250.58881121
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B38:05KHQEAMDVKEF0.99840.9778314
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-A30:01AMDVKEFKVNK0.98430.8439718
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B44:07KHQEAMDVKEF0.97420.9736314
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B44:13KHQEAMDVKEF0.97420.9736314
EPC1-L3MBTL4chr1032580090chr1863019561245HLA-B44:26KHQEAMDVKEF0.97420.9736314

Top

Potential FusionNeoAntigen Information of EPC1-L3MBTL4 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
EPC1-L3MBTL4_32580090_6301956.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0338VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0338DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0340VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0434VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0465AMDVKEFKVNKEQAE722
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0466VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0466DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0466KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0466MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0801VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0803VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0803DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0805VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0805DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0807VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0808VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0808DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0811VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0811DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0814VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0814DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0816VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0818VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0818DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0819VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0823VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0823DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0825VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0825DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0826VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0827VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0827DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0829VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0829DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0829MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0829KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0832VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0832DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0832MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0832KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0833VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0833DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0834VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0835VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0835DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0836VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0836DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0837VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0838VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0838DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0839VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0840VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0840DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0840KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0840MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0908VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-0908DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1114VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1120VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1130VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1153VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1153DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1168VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1169VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1173VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1179VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1179DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1182VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1182DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1302VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1303VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1303DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1303KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1303MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-13101VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-13101DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-13101KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-13101MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1310VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1310DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1310KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1310MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1312VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1312DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1312MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1313VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1313DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1313MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1313KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1321VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1323VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1329VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1330VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1330DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1331VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1331DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1333VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1333DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1333KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1333MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1334VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1336VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1336DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1337VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1338VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1338DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1338KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1338MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1339VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1341VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1341DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1349VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1349DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1355VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1355DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1365VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1365DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1365KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1365MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1366VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1366DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1366MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1366KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1367VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1367DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1367KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1373VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1374VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1385VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1388VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1388DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1388KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1388MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1390VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1390DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1390KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1390MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1395VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1395DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1395KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1395MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1396VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1396DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1397VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1399VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1402VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1402DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1409VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1409DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1413VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1413DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1413KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1413MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1419VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1419DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1419KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1422VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1422DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1424VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1424DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1425VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1425DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1430VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1441VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1441DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1446VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1446DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1447VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1447DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1447KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1448VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1448DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1449VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1449DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1449KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1449MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1451VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1451DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1453VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1457AMDVKEFKVNKEQAE722
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1457EAMDVKEFKVNKEQA621
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1457MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1457QEAMDVKEFKVNKEQ520
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1463VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1463DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1468VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1469VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1469DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1469KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1469MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1485VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1485DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1489VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1493VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1493DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1494VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1494DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB1-1498VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0109VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0109DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0109KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0202VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0202DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0202KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0205VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0205DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0205KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0209VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0209DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0210VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0210DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0210KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0211VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0211DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0211KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0211MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0212VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0212DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0212KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0213VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0213DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0213KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0214VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0214DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0214KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0215VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0215DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0215KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0215MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0216VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0216DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0216KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0216MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0217VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0217DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0217KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0218VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0218DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0218KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0219VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0219DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0219KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0219MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0220VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0220DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0220KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0221VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0221DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0222VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0222DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0222KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0222MDVKEFKVNKEQAEE823
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0223VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0223DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0223KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0225VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0225DVKEFKVNKEQAEEE924
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0225KEFKVNKEQAEEEKK1126
EPC1-L3MBTL4chr1032580090chr1863019561245DRB3-0303VKEFKVNKEQAEEEK1025
EPC1-L3MBTL4chr1032580090chr1863019561245DRB5-0112VKEFKVNKEQAEEEK1025

Top

Fusion breakpoint peptide structures of EPC1-L3MBTL4

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
1540EAMDVKEFKVNKEQEPC1L3MBTL4chr1032580090chr1863019561245

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of EPC1-L3MBTL4

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN1540EAMDVKEFKVNKEQ-7.9962-8.1096
HLA-B14:023BVN1540EAMDVKEFKVNKEQ-5.70842-6.74372
HLA-B52:013W391540EAMDVKEFKVNKEQ-6.83737-6.95077
HLA-B52:013W391540EAMDVKEFKVNKEQ-4.4836-5.5189
HLA-A11:014UQ21540EAMDVKEFKVNKEQ-10.0067-10.1201
HLA-A11:014UQ21540EAMDVKEFKVNKEQ-9.03915-10.0745
HLA-A24:025HGA1540EAMDVKEFKVNKEQ-6.56204-6.67544
HLA-A24:025HGA1540EAMDVKEFKVNKEQ-5.42271-6.45801
HLA-B44:053DX81540EAMDVKEFKVNKEQ-7.85648-8.89178
HLA-B44:053DX81540EAMDVKEFKVNKEQ-5.3978-5.5112
HLA-A02:016TDR1540EAMDVKEFKVNKEQ-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of EPC1-L3MBTL4

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
EPC1-L3MBTL4chr1032580090chr1863019561121KEFKVNKEQAAATAAGGAGCAAGCTGAAGAGGAAAAGAAG
EPC1-L3MBTL4chr1032580090chr186301956314KHQEAMDVKEFATGGATGTGAAGGAGTTCAAAGTTAATAAGGAG
EPC1-L3MBTL4chr1032580090chr186301956414HQEAMDVKEFGATGTGAAGGAGTTCAAAGTTAATAAGGAG
EPC1-L3MBTL4chr1032580090chr186301956514QEAMDVKEFGTGAAGGAGTTCAAAGTTAATAAGGAG
EPC1-L3MBTL4chr1032580090chr186301956614EAMDVKEFAAGGAGTTCAAAGTTAATAAGGAG
EPC1-L3MBTL4chr1032580090chr186301956616EAMDVKEFKVAAGGAGTTCAAAGTTAATAAGGAGCAAGCT
EPC1-L3MBTL4chr1032580090chr186301956716AMDVKEFKVGAGTTCAAAGTTAATAAGGAGCAAGCT
EPC1-L3MBTL4chr1032580090chr186301956718AMDVKEFKVNKGAGTTCAAAGTTAATAAGGAGCAAGCTGAAGAG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
EPC1-L3MBTL4chr1032580090chr1863019561025VKEFKVNKEQAEEEKGTTAATAAGGAGCAAGCTGAAGAGGAAAAGAAGCCCAAGGATAGC
EPC1-L3MBTL4chr1032580090chr1863019561126KEFKVNKEQAEEEKKAATAAGGAGCAAGCTGAAGAGGAAAAGAAGCCCAAGGATAGCACA
EPC1-L3MBTL4chr1032580090chr186301956520QEAMDVKEFKVNKEQGTGAAGGAGTTCAAAGTTAATAAGGAGCAAGCTGAAGAGGAAAAG
EPC1-L3MBTL4chr1032580090chr186301956621EAMDVKEFKVNKEQAAAGGAGTTCAAAGTTAATAAGGAGCAAGCTGAAGAGGAAAAGAAG
EPC1-L3MBTL4chr1032580090chr186301956722AMDVKEFKVNKEQAEGAGTTCAAAGTTAATAAGGAGCAAGCTGAAGAGGAAAAGAAGCCC
EPC1-L3MBTL4chr1032580090chr186301956823MDVKEFKVNKEQAEETTCAAAGTTAATAAGGAGCAAGCTGAAGAGGAAAAGAAGCCCAAG
EPC1-L3MBTL4chr1032580090chr186301956924DVKEFKVNKEQAEEEAAAGTTAATAAGGAGCAAGCTGAAGAGGAAAAGAAGCCCAAGGAT

Top

Information of the samples that have these potential fusion neoantigens of EPC1-L3MBTL4

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
ESCAEPC1-L3MBTL4chr1032580090ENST00000263062chr186301956ENST00000284898TCGA-L5-A4OR

Top

Potential target of CAR-T therapy development for EPC1-L3MBTL4

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to EPC1-L3MBTL4

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to EPC1-L3MBTL4

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource